 |
 |
|
Negotiating Successful Strategic Alliances and Calculating their Financial Terms
|
||
 |
 |
 |
Market News and TrendsDuring May 2006, PharmaDeals Agreements recorded an unusually high number of deals relating to drug delivery, with a total of 31. Nine of these deals were between start-up and established companies while seven other deals were between two start-up companies. Only one global company participated in a drug delivery deal during May. A total of 13 transactions involved licensing and rights agreements as well as technology access. A further 7 deals focused upon co-development and collaborative R&D arrangements. The remaining deals comprised manufacture and supply, funding and distribution deals as well as two asset and product acquisitions and one business acquisition. A wide range of drug delivery technologies were the subject of May's deals, including time-release liquid technologies, inhalers, an electroporation device, transdermal skin patches, film technology, a melt-in-the-mouth tablet and chewing gum. Read more... |
||
|
|
||
Featured ArticleRapidFilm: Oral Thin Films (OTF) as an Innovative Drug Delivery System and Dosage FormRapidFilm, a new drug delivery system for the oral delivery of drugs, was developed based on the technology of the transdermal patch. It consists of a very thing oral strip, which releases the active ingredient immediately after uptake into the oral cavity. In contrast to other existing, rapidly dissolving dosage forms, which mainly consist of lipophylisates, the RapidFilm can be produced with a manufacturing process that is competitive with the manufacturing costs of conventional tablets. In this article, Ulrike Vollmer of Labtec and Paolo Galfetti of APR Applied Pharma Research discuss the technology behind RapidFilm, its benefits and its potential in the market place. Read more... |
 |
||
|
|
||
 |
Company ProfilesAveva, Camurus, Kurve, pSivida |
||
|
|
||
Drug Delivery OpportunitiesView all our Drug Delivery Opportunities or alternatively request a password to submit your opportunity online.Featured Opportunity Sustained-Release Lipid Inhaled Targeting Drug Delivery Technology Administration Route - Inhalation Indication - Respiratory Diseases Licence code - LO-0606-01 |
 |
||
|
|
||
 |
Ensure you receive your copy of the Drug Delivery Report Spring / Summer 2006For deal makers actively assessing drug delivery technology receiving your complimentary copy is a must. The DDR blends high-quality articles covering the latest drug developments in conjunction with concise profiles of companies active in specific technology areas.Apply to receive the next edition of the DDR Find out more about promoting your company |
||
Drug Delivery E-News is produced by PharmaVentures Intelligence - part of PharmaVentures a leading results driven organisation assisting pharmaceutical and biotechnology companies worldwide in all aspects of deal making.
Comprising two specialist areas - PharmaVentures Consulting and PharmaVentures Intelligence - we work with clients to drive greater value from their deals.
If you do not wish to receive DDR E-News in future, please e-mail ddr@pharmamail.biz with the words UNSUBSCRIBE as the subject.
If you do not wish to receive other e-mail communications from PharmaVentures or selected third parties, please e-mail ddr@pharmamail.biz with REMOVE as the subject.
For more details contact
Kate Atherton, Publishing Editor, PharmaVentures Ltd, Magdalen Centre, Oxford Science Park, Oxford OX4 4GA, UK. Tel: +44 (0) 1865 784 177 Fax: +44 (0) 1865 784 178 E-mail ddr@pharmamail.biz